Search Results - "Alvarez, P Guillen"

CP-051 Comparing the efficacy of afatinib versus erlotinib or gefitinib in non-small cell lung cancer patients by Garcia-Cuevas, L Bravo, Alvarez, P Guillen, Comas, R Medina, Clavo, S Martin, Morera, D Briegas, Mangas, C Meneses, Lobato, E Garcia, Mayoral, JF Rangel

“…BackgroundAfatinib is a second generation irreversible EGFR tyrosine kinase inhibitor (TKI), indicated as firstline therapy in non-small cell lung cancer…”
Get full text

Satisfacción de las personas con diabetes mellitus tipo 2 tras iniciar tratamiento con insulina by Mancera-Romero, J, Carramiñana-Barrera, F, Muñoz-González, L, Guillén-Álvarez, P, Murillo-García, D, Sánchez-Pérez, M.R

“…Resumen Objetivos El «miedo al pinchazo» de muchos pacientes con diabetes tipo 2 (DM2) puede retrasar el inicio del tratamiento con insulina. Nuestro objetivo…”
Get full text

Satisfaction of patients with type 2 diabetes mellitus after starting treatment with insulin by Mancera-Romero, J, Carramiñana-Barrera, F, Muñoz-González, L, Guillén-Álvarez, P, Murillo-García, D, Sánchez-Pérez, M R

“…The objective of this study is to evaluate if overcoming the barrier of starting treatment with insulin can lead to better clinical control and a higher level…”
Get full text